Large company small molecule share of Phase I clinical trial starts
RecordSTO-99TTKTY67G-T4JSSS1WAT-AF78VE
Global · 2022
Large company small molecule share of Phase I clinical trial starts worldwide was 61% in 2022 (IQVIA).
Large company small molecule share of Phase I clinical trial starts: every country and year, and how it is measured
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Report
- Global R&D Trends 2026
- Locator
- Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
The recent increase in the proportion of small molecule trials in Phase I has been driven by a combination of stabilization of small molecule share among EBPs and an increasing share of small molecule trials among larger companies, where the small molecule share increased from 61% in 2022 to 66% in 2025.
Checked: the figure 61%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2022). Global R&D Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026. Via StatOrigin, https://statorigin.org/stat/stat_99TTKTY67GT4JSSS1WATAF78VE
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Global R&D Trends 2026." 2022, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_99TTKTY67GT4JSSS1WATAF78VE.
- Chicago
- IQVIA Institute. "Global R&D Trends 2026." 2022. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_99TTKTY67GT4JSSS1WATAF78VE.
- BibTeX
- @misc{iqvia2022largeaf78ve, author = {{IQVIA Institute}}, title = {Global R\&D Trends 2026}, year = {2022}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_99TTKTY67GT4JSSS1WATAF78VE}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Global R&D Trends 2026
- Type
- Press release
- Published
- —
- Locator
- Exhibit 21: Small molecule share of trial starts by phase and company segment, 2016–2025
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_99TTKTY67GT4JSSS1WATAF78VE